DUSKEY, JASON THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 4.543
EU - Europa 4.030
AS - Asia 2.956
SA - Sud America 389
AF - Africa 70
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.000
Nazione #
US - Stati Uniti d'America 4.456
SE - Svezia 1.936
SG - Singapore 969
IT - Italia 954
CN - Cina 781
HK - Hong Kong 353
VN - Vietnam 353
GB - Regno Unito 349
BR - Brasile 293
DE - Germania 156
RU - Federazione Russa 139
FI - Finlandia 125
FR - Francia 100
KR - Corea 89
ID - Indonesia 66
IN - India 61
CA - Canada 47
NL - Olanda 46
AR - Argentina 39
TR - Turchia 39
JP - Giappone 38
BG - Bulgaria 35
BD - Bangladesh 34
MY - Malesia 28
UA - Ucraina 26
PK - Pakistan 24
MX - Messico 23
ZA - Sudafrica 22
ES - Italia 21
IQ - Iraq 21
PL - Polonia 19
LT - Lituania 18
IE - Irlanda 16
CH - Svizzera 15
VE - Venezuela 15
BE - Belgio 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
RO - Romania 12
AT - Austria 11
TN - Tunisia 11
CO - Colombia 10
PH - Filippine 10
IL - Israele 9
MA - Marocco 9
TH - Thailandia 9
AU - Australia 7
DK - Danimarca 7
TW - Taiwan 7
UZ - Uzbekistan 7
CL - Cile 6
NP - Nepal 6
PT - Portogallo 6
PY - Paraguay 6
DZ - Algeria 5
ET - Etiopia 5
GR - Grecia 5
JM - Giamaica 5
SA - Arabia Saudita 5
BY - Bielorussia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
QA - Qatar 4
GE - Georgia 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
LY - Libia 3
PE - Perù 3
AM - Armenia 2
AN - Antille olandesi 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 11.989
Città #
Stockholm 1.778
Singapore 617
Santa Clara 600
Ashburn 507
Fairfield 365
Hong Kong 344
Chandler 286
Hefei 275
San Jose 251
Woodbridge 166
Seattle 149
Cambridge 142
Modena 141
Houston 139
London 133
Southend 132
Wilmington 128
Nyköping 125
Beijing 123
Los Angeles 117
Ho Chi Minh City 112
New York 112
Chicago 107
Council Bluffs 101
Helsinki 101
Bologna 87
Dallas 86
Seoul 86
Hanoi 84
The Dalles 63
Munich 58
Lauterbourg 53
Jakarta 52
Shanghai 50
Milan 44
Reggio Emilia 41
San Diego 41
Ann Arbor 38
Moscow 38
Princeton 33
Sofia 33
Rome 32
Falls Church 31
Frankfurt am Main 28
São Paulo 28
Buffalo 22
Salt Lake City 22
Tokyo 22
Da Nang 19
Dearborn 18
Orem 18
Parma 18
Phoenix 17
Jacksonville 16
Turku 16
Warsaw 16
Brooklyn 15
Johannesburg 15
Kent 15
Montreal 15
Tampa 15
Amsterdam 14
Castrezzato 14
Elk Grove Village 14
Haiphong 14
Nuremberg 14
Atlanta 13
Des Moines 13
Dublin 13
Dong Ket 12
Guangzhou 12
Redondo Beach 12
Wuhan 12
Ankara 11
Denver 11
Florence 11
Izmir 11
Redwood City 11
Brussels 10
Düsseldorf 10
Eugene 10
Mumbai 10
Portsmouth 10
Rio de Janeiro 10
Shenzhen 10
Catania 9
Mexico City 9
Naples 9
Baghdad 8
Boardman 8
Chennai 8
Ninh Bình 8
Turin 8
Vienna 8
Columbus 7
Hounslow 7
Istanbul 7
Lahore 7
Lappeenranta 7
Manchester 7
Totale 8.735
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.029
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 355
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 311
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 305
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 300
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 270
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 270
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 266
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 264
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 263
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 262
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 261
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 254
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 248
Challenges of enzyme therapy: Why two players are better than one 242
Microfluidic technology for the production of hybrid nanomedicines 234
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 228
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment 218
Tween® preserves enzyme activity and stability in PLGA nanoparticles 217
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 211
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 204
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 201
Tunneling Nanotubes: A New Target for Nanomedicine? 199
Nanoparticle ligand presentation for targeting solid tumors 199
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 198
Analysis of Molecular Parameters Determining the Antimalarial Activity of Polymer-Based Nanomimics 197
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? 193
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 191
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 191
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier 190
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 189
Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver 188
Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery 186
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 180
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs 179
Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties 177
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress 168
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 167
Chaperonin–Dendrimer Conjugates for siRNA Delivery 159
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 157
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges 153
New concepts to fight oxidative stress: Nanosized three-dimensional supramolecular antioxidant assemblies 145
PH-responsive PDMS-b-PDMAEMA micelles for intracellular anticancer drug delivery 143
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery 141
Quantitative comparison of the protein corona of nanoparticles with different matrices 135
Miniaturization of gene transfection assays in 384- and 1536-well microplates 132
Nanomedicines for brain diseases: Where we are and where we are going 126
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression 125
PH-Triggered Reversible Multiple Protein-Polymer Conjugation Based on Molecular Recognition 123
Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles 122
Drug delivery systems for mitochondrial targeting 38
Totale 12.104
Categoria #
all - tutte 47.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 77 52
2021/2022751 55 61 39 39 58 54 36 53 102 69 97 88
2022/2023797 94 80 56 77 79 108 24 85 98 19 41 36
2023/2024699 31 60 46 57 123 93 42 81 18 34 22 92
2024/20252.530 87 43 63 161 448 326 208 164 286 114 263 367
2025/20265.839 328 195 370 473 522 264 541 287 2.302 416 141 0
Totale 12.104